Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 77 (RPL21P77)

Target: RPL21P77
Molecular classification: Other

Overview

Ribosomal protein L21 pseudogene 77 (RPL21P77) is a "pseudogene"—a nonfunctional segment of DNA related by sequence similarity to the ribosomal protein L21 gene. While the functional RPL21 gene encodes a structural component of the large (60S) ribosomal subunit involved in protein synthesis[5][7], RPL21P77 itself does not produce a functional protein and is not known to fulfill any biological or therapeutic role[3][4]. Pseudogenes like RPL21P77 are considered "genomic fossils" and generally do not have a direct function, though in some cases they can play regulatory roles. There is no evidence that RPL21P77 is a therapeutic target or associated with disease, drug interactions, or specific biological functions.

Other names: RPL21_29_883[3]

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 77 (RPL21P77).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 77 (RPL21P77).

Explore the full profile